AKBA Market Cap & Key Metrics
Akebia Therapeutics, Inc.
$0.70
-$0.07(-8.83%)
39
Overall
40
Value
40
Tech
39
Quality
Market Cap
$194.53M
Volume
13.89M
52W Range
$0.80 - $3.20
Target Price
$3.80
AKBA market cap is $194.53M. This page lists Akebia Therapeutics, Inc.'s P/E ratio, EPS estimates, dividend yield, payout ratio and MarketXLS scores.
AKBA Key Metrics
- Market cap
- $194.53M
- EPS estimate, current year
- $-0.14
- EPS growth, 3-year
- +66.03%
- Value score
- 40
- Quality score
- 39
- Technical score
- 40
| Fiscal year | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Revenue | $236.20M | $160.18M | $194.62M | $292.48M | $213.58M |
| EBITDA | $21.73M | -$13.76M | -$4.05M | -$43.26M | -$228.37M |
| EPS | $-0.02 | $-0.33 | $-0.28 | $-0.51 | $-1.70 |
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Vol |
| 2 | AKBA | $0.70 | -8.8% | 13.89M |
| 3 | ||||
| 4 | ||||
| 5 | ||||
| 6 |
Get Akebia Therapeutics, Inc. Data in Excel
Stream real-time data directly to your spreadsheets
BUY NOW